Jacobs Levy Equity Management
MRNS

Jacobs Levy Equity Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Jacobs Levy Equity Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$10.9K Sell
2024
Q3 		$729K Buy
2024
Q2 		$348K Buy
2024
Q1 		$384K Buy
2020
Q4 		– Sell
2020
Q3 		$1.09M Buy
2020
Q2 		$609K Buy
2020
Q1 		$162K Sell
2019
Q4 		$330K Buy